Talphera, Inc. (NASDAQ:TLPH) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET
Company Participants
Raffi Asadorian – CFO
Vincent Angotti – CEO
Shakil Aslam – CMO
Conference Call Participants
Thomas Yip – H.C. Wainwright
Naz Rahman – Maxim Group
Operator
Welcome to the Talphera Fourth Quarter and Full Year 2024 Financial Results Conference call. This call is being webcast live via the Events page of the Investors section of Talphera’s website, www.talphera.com. You may listen to a replay of this webcast by going to the Investors section of Talphera’s website. I would now like to turn the call over to Raffi Asadorian, Talphera’s Chief Financial Officer. Please go ahead.
Raffi Asadorian
Thank you for joining us on the call today. Today we announced our fourth quarter and full year 2024 financial results and associated business updates in a press release. With me today are Vincent Angotti, our Chief Executive Officer, and Dr. Shakil Aslam, Talphera’s Chief Medical Officer.
Before we begin, I want to remind listeners that during this call, we will likely make forward-looking statements within the meeting of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Talphera. Please refer to our press release in addition to the company’s periodic, current, and annual reports filed with the Securities and Exchange Commission for a discussion of the risks associated with such forward-looking statements. These documents can also be found on our website within the Investors section.
I’ll now hand the call over to Vince.
Vincent Angotti
Thanks, Raffi. Good afternoon, and thank you to everyone joining our call today. We made strong progress in 2024 and anticipate furthering that progress in 2025 with the expectation that our NEPHRO CRRT study should be completed by the end of the year. We have a number
Read the full article here
